AMGN: Amgen Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 132,834.49
Enterprise Value ($M) 161,086.08
Book Value ($M) 9,409.00
Book Value / Share 16.27
Price / Book 14.27
NCAV ($M) n/a
NCAV / Share n/a
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) 0.17
Return on Assets (ROA) 0.12
Return on Equity (ROE) 0.75

Liquidity (mrq)
Quick Ratio 1.48
Current Ratio 1.81

Balance Sheet (mrq) ($M)
Current Assets 21,144.00
Assets 62,948.00
Liabilities 53,539.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 25,424.00
Operating Income 9,139.00
Net Income 7,264.00
Earnings Per Share Diluted 12.31
Earnings Per Share Basic 12.40

Cash Flow Statement (mra) ($M)
Cash From Operations 10,497.00
Cash from Investing -5,401.00
Cash from Financing -5,401.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-16 13G/A Capital Research Global Investors 5.50 -10.12
02-10 13G/A Vanguard Group Inc 8.11 -2.57
02-05 13G State Street Corp 5.17
01-29 13G/A BlackRock Inc. 8.20 0.00
2020-02-07 13G/A Fmr Llc 4.12 -26.05
2013-05-03 13G/A Primecap Management Co/ca/ 4.99

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2021-02-09 10-K Annual Report – 10-K
2020-10-29 10-Q Quarterly Report – 10-Q
2020-07-29 10-Q Quarterly Report – 10-Q
2020-05-01 10-Q Quarterly Report – 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2021-02-24 217,736 2,690,500 8.09
2021-02-23 362,370 2,919,000 12.41
2021-02-22 265,638 2,334,800 11.38

(click for more detail)

(click for list of largest short owners)

Similar Companies
ALXO – ALX Oncology Holdings Inc. ALZH – Alzheon, Inc.
AMBI – Ambit Biosciences Corp AMPH – Amphastar Pharmaceuticals, Inc.
AMRN – Amarin Corp. Plc


Financial data and stock pages provided by
Fintel.io